Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Bounthavong

Showing results (11-20 of 105) with videos related to

Pageof 11
Sort By:
Journal of Evaluation in Clinical Practice|September 2, 2008
Identifying health-related quality of life (HRQL) domains for multiple chronic conditions (diabetes, hypertension and dyslipidemia): patient and provider perspectivesMark Bounthavong, Anandi V Law
Expert Review of Pharmacoeconomics & Outcomes Research|December 21, 2012
Cost-effectiveness of linezolid in methicillin-resistant Staphylococcus aureus skin and skin structure infectionsMark Bounthavong, Donald I Hsu
Journal of Evaluation in Clinical Practice|May 24, 2007
Decision analysis model evaluating the cost-effectiveness of risperidone, olanzapine and haloperidol in the treatment of schizophreniaMark Bounthavong, Mark P Okamoto
Current Medical Research and Opinion|December 17, 2009
Efficacy and safety of linezolid in methicillin-resistant Staphylococcus aureus (MRSA) complicated skin and soft tissue infection (cSSTI): a meta-analysisMark Bounthavong, Donald I Hsu
Annals of Internal Medicine|November 29, 2017
Emergency Medical Services Naloxone Administration: Many Unknowns and OpportunitiesElizabeth M Oliva, Mark Bounthavong
Addiction (Abingdon, England)|October 23, 2018
Commentary on Rege et al. (2018): Naloxone reports to US poison centers highlight overdose prevention opportunitiesElizabeth M Oliva, Mark Bounthavong
Peerj|June 3, 2014
Retrospective cohort study of anti-tumor necrosis factor agent use in a veteran populationMark Bounthavong, Nermeen Madkour, Rashid Kazerooni
Journal of the American Pharmacists Association : Japha|February 8, 2026
Evaluation of the "Follow Your Heart" project: Academic detailing to improve hypertension composite quality measureAndrea Winterswyk, Mark Bounthavong, Patrick Spoutz
Research in Social & Administrative Pharmacy : RSAP|June 7, 2016
An evaluation of health care expenditures in Crohn's disease using the United States Medical Expenditure Panel Survey from 2003 to 2013Mark Bounthavong, Meng Li, Jonathan H Watanabe
Current Medical Research and Opinion|January 17, 2013
Revisiting the medication possession ratio threshold for adherence in lipid managementJonathan H Watanabe, Mark Bounthavong, Timothy Chen
Pageof 11

Showing results (11-20 of 105) with videos related to

Sort By:
Pageof 11
Journal of Evaluation in Clinical Practice|September 2, 2008
Identifying health-related quality of life (HRQL) domains for multiple chronic conditions (diabetes, hypertension and dyslipidemia): patient and provider perspectivesMark Bounthavong, Anandi V Law
Expert Review of Pharmacoeconomics & Outcomes Research|December 21, 2012
Cost-effectiveness of linezolid in methicillin-resistant Staphylococcus aureus skin and skin structure infectionsMark Bounthavong, Donald I Hsu
Journal of Evaluation in Clinical Practice|May 24, 2007
Decision analysis model evaluating the cost-effectiveness of risperidone, olanzapine and haloperidol in the treatment of schizophreniaMark Bounthavong, Mark P Okamoto
Current Medical Research and Opinion|December 17, 2009
Efficacy and safety of linezolid in methicillin-resistant Staphylococcus aureus (MRSA) complicated skin and soft tissue infection (cSSTI): a meta-analysisMark Bounthavong, Donald I Hsu
Annals of Internal Medicine|November 29, 2017
Emergency Medical Services Naloxone Administration: Many Unknowns and OpportunitiesElizabeth M Oliva, Mark Bounthavong
Addiction (Abingdon, England)|October 23, 2018
Commentary on Rege et al. (2018): Naloxone reports to US poison centers highlight overdose prevention opportunitiesElizabeth M Oliva, Mark Bounthavong
Peerj|June 3, 2014
Retrospective cohort study of anti-tumor necrosis factor agent use in a veteran populationMark Bounthavong, Nermeen Madkour, Rashid Kazerooni
Journal of the American Pharmacists Association : Japha|February 8, 2026
Evaluation of the "Follow Your Heart" project: Academic detailing to improve hypertension composite quality measureAndrea Winterswyk, Mark Bounthavong, Patrick Spoutz
Research in Social & Administrative Pharmacy : RSAP|June 7, 2016
An evaluation of health care expenditures in Crohn's disease using the United States Medical Expenditure Panel Survey from 2003 to 2013Mark Bounthavong, Meng Li, Jonathan H Watanabe
Current Medical Research and Opinion|January 17, 2013
Revisiting the medication possession ratio threshold for adherence in lipid managementJonathan H Watanabe, Mark Bounthavong, Timothy Chen
Pageof 11